The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of TATTON, a multi-arm phase Ib trial of AZD9291 combined with MEDI4736, AZD6094 or selumetinib in EGFR-mutant lung cancer.
 
Geoffrey R. Oxnard
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Genentech; Novartis; Sanofi
Patents, Royalties, Other Intellectual Property - Patent pending
 
Suresh S. Ramalingam
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Novartis
Travel, Accommodations, Expenses - AstraZeneca; EMD Serono; Pfizer
 
Myung-Ju Ahn
No Relationships to Disclose
 
Sang-We Kim
No Relationships to Disclose
 
Helena Alexandra Yu
Consulting or Advisory Role - Clovis Oncology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Incyte (Inst); Pfizer (Inst)
 
Hideo Saka
No Relationships to Disclose
 
Leora Horn
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Clovis Oncology; Helix BioPharma; Merck; Puma Biotechnology
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Koichi Goto
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Kyowa Hakko Kirin; Lilly; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Chugai Pharma; GlaxoSmithKline
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); GlaxoSmithKline (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Oxford Oncology (Inst); Quintiles (Inst); Taiho Pharmaceutical (Inst)
 
Yuichiro Ohe
Honoraria - AstraZeneca
Research Funding - AstraZeneca (Inst)
 
Mireille Cantarini
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Paul Frewer
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Michael Lahn
Employment - AstraZeneca
 
James Chih-Hsin Yang
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Clovis Oncology; Daiichi Sankyo; Lilly; Merck; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - Boehringer Ingelheim (Inst)